Therapeutic effect of herb residue fermentation supernatant on spleen‑deficient mice

  • Authors:
    • Xiaoxiao Zhao
    • Tingtao Chen
    • Fanjing Meng
    • Huan Wang
    • Puyuan Tian
    • Xianyao Tang
    • Xin Wang
    • Xiaolei Wang
    • Hongbo Xin
    • Hua Wei
  • View Affiliations

  • Published online on: November 24, 2017     https://doi.org/10.3892/mmr.2017.8150
  • Pages: 2764-2770
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To minimize the waste of active ingredients present in herb residues, in the present study, probiotics of Bacillus subtilis, Aspergillus oryzae and Lactobacillus plantarum M3 were selected to reuse herb residues from Jianweixiaoshi tablets, and the therapeutic effects of the herb residue fermentation supernatant were evaluated using a spleen‑deficient mouse model. The results of the present study indicated that the fermentation supernatant may effectively improve the immunity of mice, as measured by body weight, spleen and thymus index, and inflammatory cytokines, including interleukin (IL)‑2, IL‑4 and interferon‑γ. The viable cell count and denaturing gradient gel electrophoresis results indicated that the fermentation supernatant markedly enhanced bacterial diversity and the number of lactobacilli in mouse intestines. Therefore, the combination of the Jianweixiaoshi herb residue and probiotics provided a novel method to reuse herb residues and may in the future contribute to the treatment of spleen deficiency.

Introduction

According to the spleen-stomach theory in traditional Chinese medicine (TCM), the spleen is not anatomically, physiologically or pathophysiologically synonymous with one organ as it is in western medicine (1,2). In TCM, the term spleen is used to describe the digestive system, including its vegetative nervous system, immunity, hemopoiesis, muscle metabolism, endocrine function, hepatic metabolic function, and protein, nucleotide, energy, water and salt metabolism (1,2). Spleen deficiency is characterized by symptoms including epigastralgia, flatulence, lack of appetite, wilted complexion, loose stools, lassitude and fatigue. Spleen deficiency is one of the most common digestive diseases in China and is frequently associated with imbalances in the gastrointestinal microflora (3,4). Therefore, clinical studies are being conducted in order to identify an association between TCM and intestinal microbiota and to contribute to the treatment of spleen deficiency (1,5,6).

Jianweixiaoshi tablets were approved by the Chinese Ministry of Health as one of the national protected traditional medicines in 1995 and were listed as the first class of over-the-counter drugs in 1999. Jianweixiaoshi tablets, containing hawthorn, malt, tangerine peel, Radix Pseudostellariae and yam, are used for treatment of indigestion, anorexia and abdominal distension, via invigoration of the stomach and tonification the spleen. Jianweixiaoshi tablets have been demonstrated to promote gastrointestinal peristalsis and gastric secretion of digestive juices, and enhance the activity of pepsin, general physique and immune function (7). In China, sales of Jianweixiaoshi tablets generate >1.2 billion renminbi in income each year, although they also produce ~100,000 tons of herb residues which are primarily used in food additives (7,8).

Herb residues are by-products of TCM materials extracted by water or ethanol, and ~30–50% of the medically active ingredients remain inaccessible (9). The microorganism fermentation theory in TCM suggests that digestive enzymes, including cellulase, protease, pectinase, lignin and lipase, produced by microorganisms may effectively degrade plant cell walls, expand the intercellular region and improve the yield of extraction of active ingredients (10). In addition, microorganisms may degrade macromolecules to smaller molecules, making them accessible for direct absorption by the human body, reduce the side effects of drugs by degrading toxic substances and introduce novel therapeutic effects by biological modification. In addition, probiotics have been defined as ‘live microorganisms that, when administered in adequate amounts, confer a health benefit on the host’, including anti-carcinogenic and anti-mutagenic properties, immune stimulation and lowering of serum cholesterol (11,12). Probiotics may be used for the prevention and treatment of certain pathological conditions (13,14).

In the present study, herb residues of Jianweixiaoshi tablets were reused via probiotics, a spleen-deficient mouse model was established and the therapeutic effect of the herb residue fermentation supernatant on spleen deficiency was evaluated.

Materials and methods

Preparation of herb residue extract and fermentation supernatant

The herb residue of Jianweixiaoshi tablets was obtained from Jiangsu Yangtze River Pharmaceutical Group Company, Ltd. (Taizhou, China) and homogenized for 2 h using a pulper. Bacillus subtilis (isolated from Douchi and stored in Professor Chen's laboratory at Nanchang University), Aspergillus oryzae (isolated from Douchi and stored in Professor Chen's laboratory as above) and Lactobacillus plantarum M3 (isolated from sourdough and stored in in Professor Chen's laboratory as above) bacteria (all 108 colony forming U/ml) were used as the inoculum for the preparation of the herb residue fermentation supernatant. B. subtilis and A. oryzae were added to the herb residue for 24 h, and L. plantarum M3 was added for 24–36 h at 37°C. Fermented products were subsequently centrifuged for 30 min at 1,000 × g at 4°C in a refrigerated centrifuge (Hunan Xiangyi Laboratory Instrument Development Co., Ltd., Changsha, China) to obtain the fermentation supernatant.

Spleen-deficient mouse model and treatment

The present study was approved by the Ethical Committee of the Second Affiliated Hospital of Nanchang University (Nanchang, China) and all methods were performed in accordance with the approved guidelines.

A total of 30 specific pathogen free 6–8-week-old male C57BL/6 mice weighting 20–30 g were housed and fed a commercial diet with water ad libitum. All mice were purchased from the Hebei Center for Disease Control and Prevention (Hebei, China), housed five per cage, on a 12-h light/dark cycle at 23±2°C and at 50±10% relative humidity. To establish the spleen-deficient mice model, 20 ml/kg/day 100% rhubarb decoction (supplied by Jiangxi Provincial Hospital of Traditional Chinese Medicine, Jiangxi, China) was administered intragastrically to mice for 7 days. All control animals were treated with the equivalent volume of PBS. Subsequently, model mice were divided into 3 groups: i) The modeling group (n=10), in which mice were only administered PBS; ii) the probiotics + drug residues group (n=10), in which mice were administered herb residue fermentation supernatant (0.1 ml/20 g); and iii) the Jianweixiaoshi tablets group (n=10), in which mice were administered Jianweixiaoshi tablets (0.1 ml/20 g). Mouse feces were collected at four time-points: i) During the control stage, on day 0, prior to treatment; ii) during the modeling stage, on day 7, following treatment with rhubarb decoction; iii) during the treatment stage, on day 14, following drug treatment; and iv) during the recovery stage, on day 21. In each group, feces of three mice from the modeling, probiotics + drug residue and Jianweixiaoshi tablets groups were randomly selected and used for denaturing gradient gel electrophoresis (DGGE) analysis.

Determination of immune indices and inflammatory factors

A total of 24 h following the final drug administration, five animals in each group were sacrificed by decapitation. Tail vein method was used to obtain the whole blood, and serum was obtained by the centrifugation of clotted blood at 2,500 × g for 15 min at 4°C, and interleukin (IL)-2, IL-4 and interferon-γ (IFN-γ) were determined using ELISA kits for IL-2 (88-7024-88; Mouse IL-2 ELISA Ready-SET-Go!), IL-4 (88-7044-22; Mouse IL-4 ELISA Ready-SET-Go!) and IFN-γ (BMS606; Mouse IFN-γ Platinum ELISA; all from eBioscience; Thermo Fisher Scientific, Inc., Waltham, MA, USA) (15). Spleen and thymus were harvested from mice and weighed immediately. Thymus and spleen indices were calculated according to the following formula: Thymus or spleen index = [(weight of thymus or spleen)/body weight] × 100.

Viable cell count

Fresh fecal samples were subjected to treatment within 2 h following collection. All samples were serially diluted 10-fold with saline solution and 300-µl solutions resulting from each dilution were separately plated on a brain-heart infusion agar supplemented with 10% sterile skimmed milk (Beijing Land Bridge Technology Co., Ltd., Beijing, China) for total anaerobic bacteria, and incubated anaerobically at 37°C for 36 h. De Man, Rogosa and Sharpe agar (Oxoid; Thermo Fisher Scientific, Inc.) was used for anaerobic culture of Lactobacilli at 37°C for 24 h. Enterococci were aerobically cultured at 37°C for 24 h on Slanetz-Bartley medium agar and MacConkey agar (both from Oxoid; Thermo Fisher Scientific, Inc.) was used for aerobic culture of Enterobacteria at 37°C for 24 h (1618).

DGGE and statistical analysis

DNA was isolated using bead-beating method (19). Following phenol-chloroform extraction, DNA was precipitated with 75% ethanol and resuspended in 50 µl TE buffer (10 mM Tris-Cl, 1 mM EDTA; pH 7.6). Primers, including 357 forward (5′-TACGGGAGGCAGCAG-3′) and 519 reverse (5′-ATTACCGCGGCTGCTGG-3′), were used to amplify total bacterial DNA, and Lac1 (5′-AGCAGTAGGGAATCTTCCA-3′) and Lac2 (5′-ATTYCACCGCTACACATG-3′) were used to amplify DNA from Lactobacillus species. GC clam-in primers were selected to generate GC-enriched polymerase chain reaction (PCR) products suitable for separation by DGGE. Subsequently, a PCR was performed using the Taq DNA Polymerase kit (Takara Biotechnology Co., Ltd., Dalian, China) in a Biosci PCR system, with 30 cycles of 94°C for 30 sec, 56°C for 30 sec, and 72°C for 60 sec. Amplicons of 16S ribosomal RNA were used for sequence-separation by DGGE, as previously described (20,21). DGGE was performed on 8% polyacrylamide gels containing acrylamide, bisacrylamide, formamide and a gradient of 35–65% urea. Tris-HCl (40 mM; pH 8.0) was used as the electrophoresis buffer in a Bio-Rad DGGE system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Electrophoresis was initiated by a pre-run for 5 min at 220 V followed by run at a fixed voltage of 85 V for 16 h at 60°C. Gels were stained with AgNO3 and developed following electrophoresis. Subsequently, gels were covered with cellophane membranes and dried overnight at 4°C. DGGE patterns were subsequently normalized and analyzed using Bionumeric software (version 2.0; Applied Maths, Sint-Martens-Latem, Belgium). During the processing, lanes were defined and the background was subtracted. In the process of normalization, differences in the intensity of the lanes were compensated and the association matrix was calculated. Clustering was performed using the Pearson correlation and unweighted pair group method with arithmetic mean (UPGMA) methods.

Sequencing of DGGE bands

Bands of interest were excised from the gel using a sterile blade and incubated overnight at 4°C in Tris-EDTA buffer (pH 8.0) to allow for DNA diffusion out of the polyacrylamide matrix. The solution was used directly for further amplifications. For sequencing, eluted DNA was amplified using the same primer pairs and conditions as described above, without the GC clamp. PCR products for sequencing were purified using a QIAquick PCR purification kit (Qiagen GmbH, Hilden, Germany). PCR products were subcloned using the pMD18-T vector system I (Takara Biotechnology Co., Ltd.) according to the manufacturer's instructions. E. coli DH5α cells (Beijing Tiangen Biochemical Technology Co., Ltd., Beijing, China) were subjected to electrotransformation with recombinant plasmids. Selection of transformants was performed on lysogeny broth agar (Oxoid; Thermo Fisher Scientific, Inc.) containing 100 mg/ml ampicillin. Transformants were randomly selected and sequenced by Invitrogen (Thermo Fisher Scientific, Inc.) (2224).

Statistical analysis

Data are presented as the mean ± standard deviation. Data were analyzed using SPSS software (version 13.0; SPSS Inc., Chicago, IL, USA) using one-way analysis of variance with the least significant difference post hoc test. P<0.05 was considered to indicate a statistically significant difference.

Results

Treatment with fermentation supernatant increases body weight, thymus and spleen indices in mice

Compared with the control group, treatment with rhubarb reduced body weight, spleen index and thymus index (Fig. 1) in the modeling group, and presented depressive behavior, constipation, unkempt fur and poor appetite. Treatment with herb residue fermentation supernatant and Jianweixioashi tablets resulted in an increase in body weight, spleen index and thymus index, although these differences were not statistically significant.

Levels of IL-2, IL-4 and IFN-γ in serum

Treatment with rhubarb decreased the levels of IL-2, IL-4 and IFN-γ in the modeling group, compared with the control group. Administration of probiotics with herb residues significantly increased levels of IL-2, −4 and IFN-γ, compared with the modeling group (all P<0.05; Fig. 2). Jianweixioashi tablets significantly increased levels of IL-4, compared with the modeling group (P<0.05).

Effects of fermentation supernatant on microbial number in vivo

The effects of the fermentation supernatant on the viable number of Enterococci, Enterobacteria and Lactobacilli were determined in the present study. Viable cell counts indicated that, during the treatment stage, fermentation supernatant and Jianweixioashi tablets increased the number of Lactobacilli, and reduced the number of Enterococci and Enterobacteria, compared with the modeling group (all P<0.05; Fig. 3). During the recovery stage, fermentation supernatant significantly inhibited the growth of Enterococci and Enterobacteria, and promoted the growth of Lactobacilli, compared with the modeling group (P<0.05).

Effects of the herb residue fermentation supernatant on bacterial diversity in vivo

The results of the DGGE analysis indicated that an uncultured bacterium, L. murinus, and Enterococcus sp. were the dominant bacteria in all groups throughout the experiments. In addition, the DGGE profile indicated that treatment with rhubarb markedly reduced the band number, while the administration of fermentation supernatant and Jianweixiaoshi tablets enhanced the bacterial diversity in the treatment and recovery stages (Fig. 4; Table IA). However, the results of the UPGMA analysis demonstrated low levels of similarity between bacteria in the control, treatment and recovery stages in the probiotics + drug residues and Jianweixiaoshi tablets treatment groups.

Table I.

Strains identified from mouse intestines by denaturing gradient gel electrophoresis using bacterial primers and Bacillus primers.

Table I.

Strains identified from mouse intestines by denaturing gradient gel electrophoresis using bacterial primers and Bacillus primers.

A, Bacterial primers

Strain no.Closest relativesSimilarity, %GenBank no.

aUncultured bacterium100HQ321493.1
bLactobacillus murinus100HQ668465.1
cEnterococcus sp.100JF910016.1
dClostridium sp.100JF813180.1
eUncultured bacterium100GU606372.1
fUncultured bacterium100JF837882.1

B, Bacillus primers

Strain no.Closest relativesSimilarity, %GenBank no.

aUncultured bacterium  99HM363549.1
bUncultured bacterium100EU491355.1
cLactobacillus murinus100HQ668465.1
dUncultured bacterium100HM363550.1
eUncultured bacterium100EU475615.1
fUncultured bacterium100EU006313.1
gEscherichia fergusonii100HQ259962.1
hUncultured bacterium100FJ881122.1
Effects of the herb residue fermentation supernatant on Bacillus diversity in vivo

As demonstrated by Bacillus DGGE profiles, treatment with rhubarb induced an effect on L. murinus, and uncultured bacteria d and f (Fig. 5). L. murinus was the dominant bacterium in all groups and during all stages. In addition, treatment with rhubarb eliminated uncultured bacterium d during the modeling stage in the probiotics + drug residue treatment group, while treatment with fermentation supernatant recovered the growth of uncultured bacterium d during the treatment and recovery stages (Fig. 5; Table IB).

Discussion

Large amounts of microbes have been identified in human intestines, particularly lactic acid bacteria, forming a complex ecological community that influences physiological homeostasis and serves a role in maintaining human health, including protection against entero-pathogens, extraction of nutrients and energy, and maintenance of normal immune functions (2528). Jianweixiaoshi tablets have been demonstrated to alleviate various spleen-stomach diseases associated with intestinal bacteria, and the active ingredients identified in herb residues demonstrated a therapeutic effect on these diseases (29,30). Therefore, the combination of probiotics and herb residues may exert positive effects on spleen-stomach diseases.

In the present study, a spleen-deficient mouse model was established, which demonstrated symptoms comprising depressive behavior, constipation, unkempt fur and poor appetite (5,6). When treated with the herb residue fermentation supernatant, the mice exhibited a minor increase in body weight, spleen index and thymus index, suggesting that the fermentation supernatant was able to enhance growth and immunity in the mice.

Cytokines serve a role in immune responses. IL-2 and IFN-γ are classified as T helper 1 cytokines, and stimulate the proliferation of cytotoxic T lymphocytes, helper T lymphocytes, natural killer cells, lymphokine activated killer cells and macrophages (3134). IL-4 is a T helper 2 cytokine, serving a role in the stimulation of activated B-cells, the proliferation of T-cells and the differentiation of B cells into plasma cells, and it has additionally been implicated in the regulation of humoral and adaptive immunity (31,32). Therefore, increased production of IL-2, IL-4 and IFN-γ indicated that the fermentation supernatant enhanced the immunity of the spleen-deficient mice.

Certain diseases, including obesity, malnutrition, inflammatory bowel disease, neurological disorders and cancer, may result from microbial imbalances (3539). Considering the health-promoting effect of TCM and probiotics, fermentation supernatant may be hypothesized to enhance microbial diversity, promote the growth of probiotics and inhibit the growth of pathogens. The results of the viable cell counts in the present study indicated that the fermentation supernatant markedly enhanced the number of Lactobacilli and reduced the number of Enterococci and Enterobacteria during the treatment stage. The results of the DGGE analysis indicated that the fermentation supernatant enhanced bacterial diversity during the treatment and recovery stages. In the present study, low similarity levels between bacteria in the control, treatment and recovery stages indicated that a novel microbial balance was established by treatment with the fermentation supernatant. The diversity of bacteria in host intestines contributes to more efficient host defenses from external invasion and, therefore, the reduced number of bands in the modeling group indicated weak resistance to foreign pathogens, while enhanced diversity in the fermentation supernatant group indicated recovery of intestinal health (28,36,37,40).

In conclusion, in the present study, the therapeutic effects of herb residues from Jianweixiaoshi tablets were used for the treatment of spleen deficiency in mice in vivo. The results of the present study indicated that fermentation supernatant was able to enhance host immunity and inflammatory responses, by increasing the number and diversity of beneficial bacteria. Therefore, the present study demonstrated that the combination of Jianweixiaoshi herb residues and probiotics may, in the future, provide a novel method for the treatment of spleen deficiency.

Acknowledgements

The present study was supported by grants from the National Natural Science Foundation of China (grant nos. 81503364, 31560264, 31360377, 91639106, 81270202 and 91339113), the National Basic Research Program of China (grant no. 2013CB531103) and grants from Jiangxi Province (grant nos. 20171BCB23028 and 20175526).

References

1 

Zhang S, Zhao L, Wang H, Wang C, Huang S, Shen H, Wei W, Tao L and Zhou T: Efficacy of modified LiuJunZi decoction on functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: A randomized controlled trial. BMC Complement Altern Med. 13:542013. View Article : Google Scholar : PubMed/NCBI

2 

Si FF, Tu JF, Liu TI and Liu ZJ: The effects of superfine powder on the total anti-oxidative ability and no of sijunzi decoction in spleen-deficient mice. Prog Vet Med. 27:R28–R58. 2006.

3 

Wu XN: Current concept of Spleen-Stomach theory and Spleen deficiency syndrome in TCM. World J Gastroenterol. 4:2–6. 1998. View Article : Google Scholar : PubMed/NCBI

4 

Peng Y, Wang Z, Lu Y, Wu CF, Yang JY and Li XB: Intestinal microflora molecular markers of spleen-deficient rats and evaluation of traditional Chinese drugs. World J Gastroenterol. 15:2220–2227. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Zhao N, Zhang W, Guo Y, Jia H, Zha Q, Liu Z, Xu S and Lu A: Effects on neuroendocrinoimmune network of Lizhong Pill in the reserpine induced rats with spleen deficiency in traditional Chinese medicine. J Ethnopharmacol. 133:454–459. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Li LS, Qu RY, Wang W and Guo H: Significance of changes of gastrointestinal peptides in blood and ileum of experimental spleen deficiency rats. World J Gastroentero. 9:553–556. 2003. View Article : Google Scholar

7 

Chen T, Xiong S, Jiang S, Wang M, Wu Q and Wei H: Effects of traditional Chinese medicines on intestinal bacteria: A review. Indian J Tradit Know. 11:401–407. 2012.

8 

Meng F, Yang S, Wang X, Chen T, Wang X, Tang X, Zhang R and Shen L: Reclamation of Chinese herb residues using probiotics and evaluation of their beneficial effect on pathogen infection. J Infect Public Health. 10:749–754. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Zhou Y, Selvam A and Wong JW: Effect of Chinese medicinal herbal residues on microbial community succession and anti-pathogenic properties during co-composting with food waste. Bioresour Technol. 217:190–199. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Himmel ME, Ding SY, Johnson DK, Adney WS, Nimlos MR, Brady JW and Foust TD: Biomass recalcitrance: Engineering plants and enzymes for biofuels production. Science. 315:804–807. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Diplock AT, Aggett PJ, Ashwell M, Bornet F, Fern EB and Roberfroid MB: Scientific concepts in functional foods in Europe: Consensus document. Br J Nutr. 81:S1–S27. 1999. View Article : Google Scholar : PubMed/NCBI

12 

Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al: Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 11:506–514. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Jiang M, Deng K, Jiang C, Fu M, Guo C, Wang X, Wang X, Meng F, Yang S, Deng K, et al: Evaluation of the antioxidative, antibacterial, and anti-inflammatory effects of the aloe fermentation supernatant containing lactobacillus plantarum HM218749.1. Mediators Inflamm. 2016:29456502016. View Article : Google Scholar : PubMed/NCBI

14 

Liu D, Jiang XY, Zhou LS, Song JH and Zhang X: Effects of probiotics on intestinal mucosa barrier in patients with colorectal cancer after operation: Meta-analysis of randomized controlled trials. Medicine (Baltimore). 95:e33422016. View Article : Google Scholar : PubMed/NCBI

15 

Guo F, He H, Fu ZC, Huang S, Chen T, Papasian CJ, Morse LR, Xu Y, Battaglino RA, Yang XF, et al: Adipocyte-derived PAMM suppresses macrophage inflammation by inhibiting MAPK signalling. Biochem J. 472:309–318. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Wang X, Wu Q, Deng K, Wei Q, Hu P, He J, Liu H, Zheng Y, Wei H, Shah NP and Chen T: A novel method for screening of potential probiotics for high adhesion capability. J Dairy Sci. 98:4310–4317. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Deng K, Chen T, Wu Q, Xin H, Wei Q, Hu P, Wang X, Wang X, Wei H and Shah NP: In vitro and in vivo examination of anticolonization of pathogens by Lactobacillus paracasei FJ861111.1. J Dairy Sci. 98:6759–6766. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Li S, Chen T, Dong S, Xiong Y, Wei H and Xu F: The effects of rebaudioside A on microbial diversity in mouse intestine. Food Sci And Technol Res. 20:459–467. 2014. View Article : Google Scholar

19 

Chen T, Xiong S, Jiang S, Wang M, Wu Q and Wei H: Molecular identification of microbial community in Chinese douchi during post-fermentation process. Food Sci Biotechnol. 20:1633–1638. 2011. View Article : Google Scholar

20 

Chen T, Wu Q, Li S, Xiong S, Jiang S, Tan Q, Zhang Z, Zhu D and Wei H: Microbiological quality and characteristics of probiotic products in China. J Sci Food Agric. 94:131–138. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Chen T, Wang M, Li S, Wu Q and Wei H: Molecular identification of microbial community in surface and undersurface douchi during postfermentation. J Food Sci. 79:M653–M658. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Chen TT, Wang MJ, Li SJ, Wu QL and Wei H: Molecular Identification of Microbial Community in Surface and Undersurface Douchi During Postfermentation. J Food Sci. 79:M653–M658. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Chen T, Wang M, Jiang S, Xiong S and Wei H: The application of polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE) method in microbial screening. Afr J Biotechnol. 10:9387–9395. 2011. View Article : Google Scholar

24 

Chen T, Tan Q, Wang M, Xiong S, Jiang S, Li S, Luo C and Wei H: Identification of bacterial strains in viili by molecular taxonomy and their synergistic effects on milk curd and exopolysaccharides production. Afr J Biotechnol. 10:16969–16975. 2011.

25 

Hooper LV, Littman DR and Macpherson AJ: Interactions between the microbiota and the immune system. Science. 336:1268–1273. 2012. View Article : Google Scholar : PubMed/NCBI

26 

Nelson MH, Diven MA, Huff LW and Paulos CM: Harnessing the microbiome to enhance cancer immunotherapy. J Immunol Res. 2015:3687362015. View Article : Google Scholar : PubMed/NCBI

27 

Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML, et al: Commensal bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 350:1084–1089. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S, et al: Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 352:565–569. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Zhang ZB, Peiy Y and Liu W: Jianweixiaoshi tablets determination of hesperidin content tesr. J Pract Tradit Chin Intern Med. 4:0152011.(In Chinese).

30 

Min Y, Jing L, Jinjin M and Ting X: Effects of oridonin on activities of rabbit's intestinal smooth muscle. China Pharm. 14:0152012.

31 

Liao W, Lin JX and Leonard WJ: IL-2 family cytokines: New insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol. 23:598–604. 2011. View Article : Google Scholar : PubMed/NCBI

32 

Gaffen SL and Liu KD: Overview of interleukin-2 function, production and clinical applications. Cytokine. 28:109–123. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Wheelock EF: Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science. 149:310–311. 1965. View Article : Google Scholar

34 

Green JA, Cooperband SR and Kibrick S: Immune specific induction of interferon production in cultures of human blood lymphocytes. Science. 164:1415–1417. 1969. View Article : Google Scholar : PubMed/NCBI

35 

Browne HP, Forster SC, Anonye BO, Kumar N, Neville BA, Stares MD, Goulding D and Lawley TD: Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature. 533:543–546. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Derrien M and van Hylckama Vlieg JE: Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 23:354–366. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Kaeberlein T, Lewis K and Epstein SS: Isolating ‘uncultivable’ microorganisms in pure culture in a simulated natural environment. Science. 296:1127–1129. 2002. View Article : Google Scholar : PubMed/NCBI

38 

Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, Zeng L, Chen J, Fan S, Du X, et al: Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol Psychiatry. 21:786–796. 2016. View Article : Google Scholar : PubMed/NCBI

39 

Forsythe P, Kunze W and Bienenstock J: Moody microbes or fecal phrenology: What do we know about the microbiota-gut-brain axis? BMC Med. 14:582016. View Article : Google Scholar : PubMed/NCBI

40 

Karst SM: The influence of commensal bacteria on infection with enteric viruses. Nat Rev Microbiol. 14:197–204. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

February-2018
Volume 17 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao X, Chen T, Meng F, Wang H, Tian P, Tang X, Wang X, Wang X, Xin H, Wei H, Wei H, et al: Therapeutic effect of herb residue fermentation supernatant on spleen‑deficient mice. Mol Med Rep 17: 2764-2770, 2018
APA
Zhao, X., Chen, T., Meng, F., Wang, H., Tian, P., Tang, X. ... Wei, H. (2018). Therapeutic effect of herb residue fermentation supernatant on spleen‑deficient mice. Molecular Medicine Reports, 17, 2764-2770. https://doi.org/10.3892/mmr.2017.8150
MLA
Zhao, X., Chen, T., Meng, F., Wang, H., Tian, P., Tang, X., Wang, X., Wang, X., Xin, H., Wei, H."Therapeutic effect of herb residue fermentation supernatant on spleen‑deficient mice". Molecular Medicine Reports 17.2 (2018): 2764-2770.
Chicago
Zhao, X., Chen, T., Meng, F., Wang, H., Tian, P., Tang, X., Wang, X., Wang, X., Xin, H., Wei, H."Therapeutic effect of herb residue fermentation supernatant on spleen‑deficient mice". Molecular Medicine Reports 17, no. 2 (2018): 2764-2770. https://doi.org/10.3892/mmr.2017.8150